Back to Companies
Emergent BioSolutions Inc.
EBSNYSECIK: 0001367644
Emergent BioSolutions Inc. (EBS) shows 43 recent insider filings from 17 insiders, with all of them on the sell side. With $0 in purchases and $1.3M in sales, the recent tape is heavily weighted toward selling (net sales of $1.3M). LINDAHL RICHARD S (EVP, Chief Financial Officer) is the most active by dollar volume, and the single largest transaction was $2.6M by PAPA JOSEPH C. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$11.9M
Purchases
$0
Sales
$1.3M
Unique Insiders
17
Recent Insider Trades
43 loaded
| Aug 12 | EBS Emergent BioSolutions Inc. | Duatschek Stephanie | EVP, CGO | Other | $0 |
| Jul 2 | EBS Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | Sell | $25.2K |
| Jun 10 | EBS Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | Tax withheld | $5.6K |
| Jun 10 | EBS Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality & Ethics, and CPL | Tax withheld | $16.1K |
| Jun 10 | EBS Emergent BioSolutions Inc. | Hartzel William | SVP, Bioservices | Tax withheld | $13.9K |
| Jun 10 | EBS Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, Chief Financial Officer | Tax withheld | $31.7K |
| May 4 | EBS Emergent BioSolutions Inc. | Zoon Kathryn C | Director | Sell | $144.5K |
| May 4 | EBS Emergent BioSolutions Inc. | Katkin Keith | Director | Sell | $128.2K |
| May 4 | EBS Emergent BioSolutions Inc. | FOWLER JOHN D JR | Director | Grant | $90.3K |
| May 4 | EBS Emergent BioSolutions Inc. | Fowler Neal Franklin | Director | Grant | $90.3K |
| May 4 | EBS Emergent BioSolutions Inc. | Richard Ronald | Director | Grant | $90.3K |
| May 4 | EBS Emergent BioSolutions Inc. | White Marvin L | Director | Grant | $90.3K |
| May 4 | EBS Emergent BioSolutions Inc. | Harsanyi Zsolt | Chairman, Director | Grant | $90.3K |
| May 4 | EBS Emergent BioSolutions Inc. | Dayal Sujata Tyagi | Director | Sell | $115.6K |
| May 4 | EBS Emergent BioSolutions Inc. | DeGolyer Donald W | Director | Sell | $130.0K |
| May 1 | EBS Emergent BioSolutions Inc. | Perl Jessica | SVP, General Counsel, Corp Sec | Grant | $0 |
| May 1 | EBS Emergent BioSolutions Inc. | Hartzel William | SVP, Bioservices | Grant | $0 |
| May 1 | EBS Emergent BioSolutions Inc. | Lowry Simon C | SVP, R&D, CMO | Grant | $0 |
| May 1 | EBS Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality & Ethics, and CPL | Grant | $0 |
| May 1 | EBS Emergent BioSolutions Inc. | PAPA JOSEPH C | President and CEO, Director | Grant | $0 |
| May 1 | EBS Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, Chief Financial Officer | Grant | $0 |
| Mar 5 | EBS Emergent BioSolutions Inc. | Hartzel William | SVP, Bioservices | Award | $483.2K |
| Mar 5 | EBS Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, Chief Financial Officer | Award | $854.6K |
| Mar 5 | EBS Emergent BioSolutions Inc. | FOWLER JOHN D JR | Director | Grant | $45.0K |
| Mar 5 | EBS Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality & Ethics, and CPL | Award | $472.3K |
| Mar 5 | EBS Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | Award | $482.4K |
| Mar 5 | EBS Emergent BioSolutions Inc. | PAPA JOSEPH C | President and CEO, Director | Award | $2.6M |
| Mar 5 | EBS Emergent BioSolutions Inc. | Lowry Simon C | SVP, R&D, CMO | Award | $492.8K |
| Mar 5 | EBS Emergent BioSolutions Inc. | Perl Jessica | SVP, General Counsel, Corp Sec | Award | $474.4K |
| Mar 5 | EBS Emergent BioSolutions Inc. | FOWLER JOHN D JR | Director | Other | $0 |
| Feb 10 | EBS Emergent BioSolutions Inc. | Perl Jessica | SVP, General Counsel, Corp Sec | Tax withheld | $10.1K |
| Feb 10 | EBS Emergent BioSolutions Inc. | Hartzel William | SVP, Bioservices | Tax withheld | $69.9K |
| Feb 10 | EBS Emergent BioSolutions Inc. | Williams Paul Anthony | SVP, Products Business | Tax withheld | $105.7K |
| Feb 10 | EBS Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality & Ethics, and CPL | Tax withheld | $346.2K |
| Feb 10 | EBS Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, Chief Financial Officer | Tax withheld | $565.6K |
| Dec 9 | EBS Emergent BioSolutions Inc. | Richard Ronald | Director | Sell | $263.1K |
| Nov 10 | EBS Emergent BioSolutions Inc. | Dayal Sujata Tyagi | Director | Sell | $85.5K |
| Oct 17 | EBS Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, Chief Financial Officer | Tax withheld | $48.0K |
| Oct 16 | EBS Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | $306.1K |
| Aug 18 | EBS Emergent BioSolutions Inc. | Zoon Kathryn C | Director | Sell | $62.9K |
| Aug 13 | EBS Emergent BioSolutions Inc. | DeGolyer Donald W | Director | Sell | $67.8K |
| Jul 15 | EBS Emergent BioSolutions Inc. | Hartzel William | SVP, Bioservices | Tax withheld | $31.4K |
| Mar 6 | EBS Emergent BioSolutions Inc. | LINDAHL RICHARD S | EVP, Chief Financial Officer | Other | $2.2M |
43 filings